Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
INmune Bio, Inc. (INMB) had Weighted-Average Shares Outstanding (Diluted) of 26.59M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-6.47M |
|
-- |
|
-- |
|
$7.43M |
|
$-7.43M |
|
$0.96M |
|
$-6.47M |
|
$-6.47M |
|
$-6.47M |
|
$-6.47M |
|
$-6.47M |
|
$-6.47M |
|
$-7.43M |
|
$-7.43M |
|
26.59M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
26.59M |
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$30.67M |
|
$0.88M |
|
$2.69M |
|
$33.36M |
|
$7.36M |
|
-- |
|
$0.62M |
|
$7.98M |
|
$25.38M |
|
$25.38M |
|
$25.38M |
|
26.59M |
|
| Cash Flow Statement Financials | |
$-19.64M |
|
$-0.90M |
|
$27.55M |
|
$20.92M |
|
$27.73M |
|
$6.81M |
|
$6.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-25.50% |
|
-25.50% |
|
-19.40% |
|
-25.50% |
|
$0.95 |
|
$-0.77 |
|
$-0.74 |
|